Episode 2: LEAP 017 – study: efficacy and safety of lenvatinib + pembrolizumab versus standard-of-care in previously treated mCRC
This content is accessible exclusively to verified healthcare professionals.
If you are a registered user, please log in here.
If you do not yet have an account, please register here.
Thank you for your understanding.